Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
The Burrill Report
»
Articles
»
GETA.OB
|
The Burrill Report
208
Followers
2
Following
You are currently following The Burrill Report
Stop Following
You are no longer following The Burrill Report
Profile
Articles (59)
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
on Nov 01, 2009
•
ARYX
,
GETA.OB
,
ICGN
More on GETA.OB by The Burrill Report
Instablogs »
StockTalks »
Comments »
Articles by Ticker
A
,
ABT
,
ACOR
,
ADM
,
AEZS
,
AFPC
,
ALDH
,
ALIOF.PK
,
ALPMF.PK
,
ALTU
,
AMGN
,
AMLN
,
ANDS
,
ANSV
,
APPA
,
ARIA
,
ARKTF.PK
,
ARYX
,
AVGN
,
AVII
,
AZN
,
BFRE.OB
,
BIIB
,
BIOVY.PK
,
BMTI
,
BMY
,
BPA
,
BVF
,
BYERF.PK
,
CADX
,
CBST
,
CCM
,
CEGE
,
CELG
,
CEPH
,
CGRB
,
CHTT
,
CLDA
,
CLDX
,
CNSO.OB
,
CPIX
,
CRA
,
CRGN
,
CRXX
,
CTIC
,
CVM
,
CYTK
,
CYTX
,
DCGN
,
DHR
,
DNA
,
DNDN
,
DYAX
,
EDEN
,
ELN
,
ELXR
,
EM
,
ENDP
,
EPIX
,
ESRX
,
EXEL
,
FACT
,
FCSC.OB
,
FRX
,
GE
,
GENZ
,
GERN
,
GETA.OB
,
GILD
,
GNMSF.PK
,
GSK
,
GTXI
,
HALO
,
HGSI
,
HLCS
,
HNAB
,
ICGN
,
IDIX
,
IMCL
,
IMGN
,
IMMU
,
INCY
,
INHX
,
ISIS
,
ISPH
,
ITMN
,
IYH
,
IYR
,
JAV
,
JNJ
,
KERX
,
LGND
,
LIFE
,
LJPC
,
LLY
,
LXRX
,
LZAGF.PK
,
MAPP
,
MATK
,
MBRX
,
MDCO
,
MDVN
,
MDZ
,
MEDX
,
MIPI
,
MITI
,
MJN
,
MNKD
,
MNOV
,
MNTA
,
MRK
,
MSFT
,
MYL
,
MYRX
,
NABI
,
NKBP
,
NKTR
,
NVO
,
NVS
,
OGXI
,
OMER
,
ONXX
,
OPXA
,
OREX
,
OSCI
,
OSIP
,
PARD
,
PEIX
,
PFE
,
PG
,
PKNGF.PK
,
PPDI
,
PRU
,
QGEN
,
RDY
,
REGN
,
RGEN
,
RHHBY.PK
,
RIGL
,
RPRX
,
RXII
,
SEM
,
SEPR
,
SGEN
,
SGMO
,
SGP
,
SHPGY
,
SLF
,
SLFPF.PK
,
SNY
,
SOMX
,
SPHDF.PK
,
STEM
,
SUPG
,
SVNT
,
SVYSY.PK
,
SYT
,
TEVA
,
TGEN
,
TKPHF.PK
,
TLCR
,
TMO
,
TPTX
,
TRBN
,
TRGT
,
TSMA
,
TSPT
,
TTHI
,
TTP
,
UGNE.OB
,
VAR
,
VION.OB
,
VRNM
,
VRTX
,
VRX
,
VVUS
,
WCRX
,
WPI
,
WYE
,
XLV
,
ZGEN
Latest Comments on The Burrill Report's Articles
Krishnendu Saha
on
Sanofi-Aventis Reaches over the Counter
: Just wondering whether Lovenox, Plavix & Ambien can ever be OTC...
more »
DanHaszard
on
Lilly Prepares for Patent Loss in Psychosis Drug, Moves into Arthritis Market
: Addictive Zyprexa was pushed by Lilly Drug Reps. They called it...
more »
On Point Advisor
on
Sanofi-Aventis Reaches over the Counter
: please see story in OTC Product News [www.otcproductnews.com]
more »
jay brebner
on
This Week's Biotech Deal-Making and Financing
: Aveo is definitely the company to own for the long haul as well as...
more »
Factation
on
This Week's Failed Trials, Missed Targets in Biotech
: Relating to, "A gel designed to prevent AIDS infections produced...
more »
johnnysize
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: Thanks Monkeys... I now own a cheap takeout stock with huge growth...
more »
Alessandro
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: I saw a television special espousing the benefits of biochar and...
more »
Alessandro
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: On Dec 13 07:47 PM auto44 wrote: > You are supposed to sell BS...
more »
BioGuy
on
Biotech's Latest Failed Trials, Missed Targets
: I think ZymoGenetics was smart to change it's focus to creating...
more »
Erich J Knight
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: All political persuasions agree, building soil carbon is GOOD. To...
more »
auto44
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: You are supposed to sell BS not buy it. On Dec 13 10:13 AM...
more »
johnnysize
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: oh gee...thats option expiration ...wow. maybe now proration...
more »
uncle mike
on
Life Sciences Co. Execs Enjoying Pay Hikes in the Downturn
: bios are always iffee but if you pick them right buy in and out...
more »
valuestocksonly
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: BFRE is going to play a large role in this nations energy...
more »
Walt17
on
Eli Lilly Plans Innovation Strategy to Counter Generics Threat
: Lilly acknowledges the generic competition. Why does this surprise...
more »
Latest Comments on The Burrill Report's Articles
Latest Comments on The Burrill Report's Articles